Michael S. Gunter, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 1,700 shares at $3.60 ($6K) on 2011-09-14, disclosed to the SEC on 2011-09-15.
Open-market purchase of $6k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.55 | 100 | $355 | 5.8% |
| 2 | $3.55 | 600 | $2K | 35.0% |
| 3 | $3.60 | 100 | $360 | 5.9% |
| 4 | $3.60 | 900 | $3K | 53.2% |
| Total | $3.58 avg | 1,700 | $6K | 100% |
| Filing → |
| HRT | BUY | 2012-12-10 | $239 | — | Filing → |
| HRT | BUY | 2012-02-14 | $1K | — | Filing → |
| HRT | BUY | 2011-12-15 | $2K | — | Filing → |